Formation, Antibiotic Resistance, and Control Strategies of <em>Staphylococcus epidermidis</em> Biofilm by Chen, Wei et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Formation, Antibiotic Resistance, 
and Control Strategies of 
Staphylococcus epidermidis Biofilm
Wei Chen, Ting-Ting Xie and Hong Zeng
Abstract
Staphylococcus epidermidis, member of the group of coagulase-negative 
staphylococci, belongs to an opportunistic pathogen. It is reported that the major 
pathogenicity of S. epidermidis is attributed to its biofilm formed on the surface of 
infected tissues, which enhances bacterial resistance to antibiotics. Thus, how to 
inhibit biofilm formation and screening biofilm inhibitors will have great value in 
reducing bacterial drug-resistance, which is beneficial to prevent and treat biofilm-
associated infections. In this chapter, we present the current knowledge on forma-
tion, antibiotic resistance, and control strategies of S. epidermidis biofilm. First, 
biofilm formation in S. epidermidis, including factors involved in different phases in 
the process of biofilm, is analyzed. Second, the mechanisms of antibiotic resistance 
in S. epidermidis biofilms, such as poor antibiotic penetration, slow growth, and 
formation of persister cells, are introduced. Finally, control strategies to S. epider-
midis biofilm formation are provided.
Keywords: Staphylococcus epidermidis, biofilm, antibiotic resistance, biofilm 
inhibition
1. Introduction
Staphylococcus epidermidis is a commensal inhabitant of human and animal skin 
that rarely causes disease in healthy persons and animals. In recent years, however, 
S. epidermidis has been the most prevalent species isolated from device-associated 
infections [1]. The ability of biofilm formation by S. epidermidis is an important rea-
son that investigators pay more attention to this emerging pathogen in recent years. 
It is reported that the major pathogenicity of S. epidermidis is attributed to its bio-
film formed on the surface of infected tissues, which enhances bacterial resistance 
to antibiotics [2]. Biofilm formation by S. epidermidis involves two major steps. 
After finishing initial attachment, bacteria accumulate and form a multilayered 
architecture [3]. Bacteria develop biofilm by producing high-viscosity extracellular 
matrices including polysaccharides (EPS), proteins, and DNA (eDNA).
There is an increasing amount of biofilm research aimed at exploring how bac-
teria control their biofilm formation and to discover nontoxic compounds that can 
attenuate biofilm formation without allowing bacteria to develop drug resistance 
[4]. Special plants and Actinomycetes are both rich sources of bioactive substances, 
notably antibiotics, enzymes, enzyme inhibitors, and pharmacologically active 
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agents [4, 5]. Moreover, some Actinomycete species were reported to produce 
inhibitors against biofilm formation by Staphylococcus aureus, Escherichia coli, and 
Pseudomonas aeruginosa [6–9].
With this background, we aim to present the current knowledge on biofilm 
formation of S. epidermidis and review the control strategies to biofilm.
2. Biofilm formation in S. epidermidis
S. epidermidis infections are regarded as prototypic biofilm infections. The 
process of biofilm formation by S. epidermidis is periodically dynamic. Also, 
surface adhesion between planktonic bacterial cells is a key for biofilm formation. 
Once several cells succeed in adhering on a surface, named initial attachment of 
cells, surface motility and binary division result in an aggregation of attached 
cells. These primary cell aggregates produce exopolymers, including exopolysac-
charides and extracellular proteins, which form extracellular matrix. Some of those 
factors may also originate from lysed cells, such as extracellular DNA (eDNA) 
[10]. Subsequently, there is development of a multicellular, multilayered biofilm 
architecture. In the later phase of biofilm formation, biofilm cells and clusters can 
detach. This detachment process is of key importance for the dissemination of 
biofilm-associated infection [10].
2.1 Factors involved in primary attachment in S. epidermidis biofilm formation
Nonspecific adhesions between bacterial cells, which are mainly attributed to 
the composition of compounds on the surface of bacterial cells and their hydropho-
bicities, play an important role in biofilm formation. Additionally, autolysin (AtlE) 
and teichoic acids have influences on biofilm formation [11, 12]. It is reported that 
lots of autolysin enhanced the cell surface hydrophobicity and increased the biofilm 
formation. Also, teichoic acids correlated with increased cell surface hydrophobic-
ity, so they contributed to biofilm formation [11, 12].
In vivo primary attachment occurs to host tissue or host matrix proteins. 
S. epidermidis produces a variety of surface proteins binding host proteins in a 
specific manner. Bacterial surface proteins with such capacities have been termed 
microbial components recognizing adhesive matrix molecules (MCRAMM) [13]. 
The C-terminus of such bacterial surface proteins consists of an LPxTG (Leu-Pro-
x-Thr-Gly) motif containing Gram-positive cell wall anchor, which covalently links 
to the cell wall [1]. According to genomic analyses, S. epidermidis has at least 14 
MCRAMMs with an LPxTG motif. Many of those belong to the serine-aspartate 
(SD)-repeat-containing protein family (called Sdr). The SD-repeat region spans 
the cell wall and extends the ligand-binding region from the surface of the bacteria 
[14]. Adequate SD repeats within proteins are essential for outstanding from bacte-
rial cell surface, which are covalently anchored to the peptidoglycan of Gram-
positive bacteria.
The SD repeat family protein Sdr G in S. epidermidis, which is very similar 
to a fibrinogen-binding protein (Fbe), is necessary and sufficient for binding to 
fibrinogen-coated material. SdrG knock-out mutant showed less adhesion on 
fibrinogen-coated surfaces. It is reported that in vivo anti-SdrG antibody decreased 
the numbers of S. epidermidis cells adherent to biomaterials [14]. One of Sdr 
proteins, SdrF, mediates binding to type I collagen via one or both ɑ1 chains, named 
collagen-binding protein [15].
Some of surface proteins on bacterial cell wall are adherent to host cells via non-
covalent interaction, such as hydrophobic bonds and Van der Waals’ force, which of 
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process are involved into the polymers on bacterial cell surface, e.g., teichoic acids. 
Teichoic acids are main components consisting of the cell wall of Gram-positive. 
They bind to peptidoglycan of cell wall and influence the activity of autolysin 
(AtlE). AtlE, encoded by the atlE gene, is a bifunctional autolysin: one is able to 
mediate bacterial adhesion, and the other is to promote bacterial cell autolysis, 
which releases DNA out of cells, named extracellular DNA (eDNA) [16].
2.2  Factors responsible for cellular aggregation in S. epidermidis biofilm 
formation
Following the primary attachment of cells to a surface, bacterial cells occur to 
accumulate with the help of a variety of associated-accumulation factors, such as 
polysaccharide intercellular adhesin (PIA), accumulation-associated protein (Aap), 
and so on.
In the process of biofilm formation by S. epidermidis, PIA plays an important role 
in cell aggregation. Studies with S. epidermidis mutant revealed that the accumula-
tion-defective mutants were unable to form a biofilm as they were unable to display 
intercellular aggregation or to produce PIA [17]. Further characterization of this S. 
epidermidis mutant showed that a deletion of icaR gene was found to upregulate PIA 
expression, providing evidence that this gene negatively regulates the PIA expres-
sion [17]. However, it is reported that there is no ica operon in some of clinical S. 
epidermidis strains, which have capacity of biofilm formation, named ica or PIA-
independent type. In these strains, the accumulation-associated protein (Aap) is a 
major factor contributing to exopolysaccharide-independent biofilms of S. epider-
midis [1]. Aap protein promotes cell-cell adhesion via a Zn2+-dependent mechanism 
[18]. It is reported that 90% of isolated S. epidermidis strains contain aap gene, which 
is implicated in both PIA-dependent and PIA-independent biofilm formations of 
S. epidermidis [18]. S. epidermidis ATCC 35984 is a ica+ strain and a biofilm former, 
whose biofilm formation mainly depends on PIA consisting of reducing polysaccha-
rides in which dihydroxyl groups are unsubstituted. However, exopolysaccharides in 
ica− S. epidermidis mainly consist of nonreducing polysaccharides [19].
2.3 Biofilm formation and maturation
Cellular aggregation constantly occurs and subsequently forms biofilm. 
Disruptive molecules create channels in the biofilm, which are essential for nutrient 
accessibility in deeper biofilm layers and give the biofilm its characteristic struc-
ture, often described as mushroom-like shapes [10]. The characteristic structure 
of mature biofilms with mushroom-like shapes and channels is dependent on the 
production of phenolsoluble modulins (PSMs) in S. epidermidis.
Of primary importance for dissemination of biofilm-associated infection, cells 
or cell aggregates may detach from a mature biofilm to reach the next infection 
sites. This may occur by mechanical forces under flow, such as present in a blood 
vessel, in a process often called sloughing [10]. Additionally, the bacteria can trigger 
detachment by PSM production. These surfactant-like molecules work by decreas-
ing noncovalent adhesion between bacterial cells.
3. Mechanisms of antibiotic resistance in S. epidermidis biofilms
Several in vitro studies have demonstrated that bacteria within biofilms are 
more resistant against antibiotic treatment as compared to planktonic cultures of 
the same strains [20].
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S. epidermidis and other bacterial species produce an extracellular matrix called 
glycocalyx or slime, which is a highly hydrated complex composed of teichoic acids, 
proteins, and exopolysaccharides. In biofilms, poor antibiotic penetration, nutrient 
limitation and slow growth, and formation of persister cells are hypothesized to be 
responsible for drug resistance.
3.1 Antibiotic penetration of biofilms
Biofilms are typically characterized by dense, highly hydrated clusters of 
bacterial cells enclosed in a self-produced polymeric matrix that is primarily 
composed of exopolysaccharides such as polysaccharide intercellular adhesin 
(PIA) in staphylococci and adherent to a surface. This matrix, also termed slime 
or extracellular polymeric substance (EPS), impairs the access of antimicrobial 
agents to the bacterial cells [21]. Additionally, either a reaction of EPS with or its 
adsorption to the components of the biofilm matrix can delay penetration of the 
antibiotics through the biofilm matrix. The effective diffusion coefficients of sol-
utes in biofilms average about 40% of the respective diffusion coefficient in pure 
water [20]. S. epidermidis slime has been found to remarkably decrease the activ-
ity of the glycopeptides vancomycin and teicoplanin. The efficacy of cloxacillin, 
amoxicillin/clavulanic acid, imipenem, cefpirome, erythromycin, roxithromycin, 
clindamycin, fusidic acid, trimethoprim/sulfamethoxazole, doxycycline, genta-
micin, tobramycin, netilmicin, amikacin, isepamicin, ofloxacin, ciprofloxacin, 
and daptomycin is also moderately affected by the exopolysaccharide matrix of S. 
epidermidis. Other studies have suggested that S. epidermidis glycocalyx reduces 
susceptibility to pefloxacin and moderately affects the activity of daptomycin, 
linezolid, and quinupristin/dalfopristin [22, 23]. The role of biofilm matrix in 
retarding the penetration of antibiotics is thereby contributed to the drug resis-
tance of S. epidermidis biofilms.
3.2 Slow cell growth in biofilms
Slow cell growth of the bacterial has been found in mature biofilms [17]. This 
phenomenon is responsible for the decreased susceptibility of bacteria in biofilms to 
antibiotics requiring growing organisms for their bactericidal effects. For example, 
penicillins and cephalosporins prefer to killing the growing bacterial cells, and the 
rate of killing cells is proportional to the growth rate [17]. It is well known that most 
antimicrobial agents act on certain types of macromolecular synthesis to exert anti-
microbial activities, such as the synthesis of enzymes, proteins, and nucleic acids 
(DNA or RNA). Thus, these antibiotics have little effects on bacteria with stagnant 
macromolecular synthesis, which leads to bacterial drug resistance.
Nutrition restriction is one of reasons that are responsible for slow cell growth. 
The mechanism of nutrition restriction is closely related to the osmotic restriction. 
Due to the existence of biofilm osmotic restriction, nutrients are not easy to pass 
through biofilm, which leads to the lack of nutrition in biofilm and slows down the 
growth rate of inner layer bacteria. This slow growth state of inner layer bacteria 
also forms a protective mechanism, which reduces the susceptibility of bacteria to 
antibiotics [24].
When the biofilm cells are exposed to antibiotics, the bacteria on the surface of 
the biofilm are killed by the drug, and the cells in the middle and deep layers of the 
biofilm are not affected. After the antibiotic treatment stops, the remaining bacteria 
will use dead bacteria as nutrients to reproduce rapidly, which can only take a few 
hours to reproduce [25, 26].
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3.3 Formation of persister cells
Delayed penetration of the antibiotics through the biofilm matrix and slow 
rate of bacterial reproduction in biofilm cannot explain entirely the resistance of 
biofilms to one important class of antibiotics, namely the fluoroquinolones. This 
class of antimicrobial agents equilibrates across bacterial biofilms and exerts bac-
tericidal effect on nondividing cells [17]. Although a dose-dependent bactericidal 
action was observed in P. aeruginosa biofilms by the fluoroquinolones ofloxacin and 
ciprofloxacin, a further increase in the antibiotic concentration or a prolonged drug 
action period did not improve killing rates after an initial 3- to 4-log drop bacterial 
counts. This result suggested that a small portion of “persister” cells occurs after 
administration of fluoroquinolones [17, 27, 28]. The most significant difference 
between persisters and mutant resistant strains is that the drug resistance of persist-
ers is only a phenotypic variation without gene mutation, so this phenotype is not 
genetic. These strains were collected, recultured, and detected the drug resistance. 
It was intriguing that the drug resistance disappeared, and the minimum inhibitory 
concentrations (MICs) were the same level as those of parent strains. Meanwhile, 
the resistant strains caused by mutation showed a stable genetic drug resistance, 
and MICs were higher than those of parent strains [28].
Persister cells in biofilms are considered to the key in the extraordinary survival 
properties of biofilms. The dynamic features of biofilm formation and shedding of 
cells from one biofilm to form a new biofilm may also explain the chronic nature 
of biofilm infections and the need for extending antimicrobial agent treatment to 
disturb the dynamics of biofilm formation [17].
4. Control strategies to S. epidermidis biofilm formation
Because the expression of toxins and other virulence factors is less in S. epider-
midis, the biofilm forming capacity is its major virulence factor. Biofilm growth 
is characterized by high resistance to antimicrobial agents and host immune 
responses, making biofilm eradication tremendously difficult. The increasing 
prevalence of multidrug-resistant S. epidermidis strains additionally hampers 
antimicrobial therapy. Therefore, targeting factors expressed at different phases in 
biofilm formation might offer new tools to combat S. epidermidis infections.
4.1 Inhibition of initial attachment
The first step of biofilm formation is bacterial adherence to the host cell surface. 
Direct binding to host cell surface is mediated by electrostatic and hydrophobic 
interactions and van der Waals forces and affected by physicochemical variables [29].
Found in our research, after investigating the antibiofilm activities of spent 
media from 185 Actinomycete strains using two S. epidermidis strains (ATCC 35984 
and a clinical strain 5-121-2) as target bacteria, three strains of tested Actinomycete 
(TRM 46200, TRM 41337, and TRM 46814) showed a significant inhibition against 
S. epidermidis biofilm formation without affecting the growth of planktonic cells. 
Effect of Actinomycete supernatants on cell surface hydrophobicity (CSH) of S. epi-
dermidis was measured by Microbial Adhesion to Hydrocarbon (MATH) assay. The 
adhesion of staphylococci to n-hexadecane was used to measure the hydrophobicity 
of S. epidermidis. All the crude proteins from spent media showed a reduction in the 
CSH against S. epidermidis ATCC 35984 and 5-121-2, which explain at least in part 
the inhibitory effect of Actinomycete supernatants on biofilm reduction [19].
Bacterial Biofilms
6
Moreover, apart from physico-chemical determinants, it was demonstrated 
that the major autolysine AtlE is involved in attachment to polystyrene sur-
faces. Therefore, AtlE may be indirectly involved in cell adhesion via releasing 
DNA. Treatment of S. epidermidis cells with DNaseI was found to inhibit biofilm 
formation at an early time point, suggesting that release of DNA also contributes to 
the attachment of S. epidermidis to artificial surfaces [30]. In our research, we per-
formed the degradation of the crude proteins from spent media against S. epidermi-
dis DNA. The crude protein from spent media of TRM 46200 showed a significant 
DNA-degradation activity. Importantly, the crude protein from spent medium of 
TRM 41337 possessed the highest DNA-degradation activity as that of the positive 
control, 10 μg/ml of DNaseI [19].
S. epidermidis foreign-associated infections occurring early are thought to 
involve direct interactions of the bacterial surface with host extracellular matrix 
(ECM). Specific binding to surface ECM proteins involves cell wall-associated 
adhesins known as MSCRAMMs (microbial surface components recognizing 
adhesive matrix molecules) [31, 32]. The recent studies have shown that antibodies 
against cell surface components of S. epidermidis can affect the rate of biofilm for-
mation or adherence of these bacteria to medical devices in vitro. Using polyclonal 
antibodies against a fibrinogen-binding protein from S. epidermidis (Fbe) could 
block adherence of S. epidermidis to fibrinogen-coated catheters in vitro [33, 34]. 
Consequently, all these surface-located components are good candidates for vaccine 
development aiming at the inhibition of the initial attachment step of biofilm 
formation.
4.2 Inhibition of bacterial accumulate
After adherence to the host cell surface, biofilms develop through intercellular 
aggregation. The major factor involved in intercellular adhesion is polysaccharide 
intercellular adhesin (PIA). The de-acetylation of PIA is not only essential for 
biofilm formation but also crucial for S. epidermidis virulence [29]. Hence, PIA was 
one of the first targets evaluated in view of biofilm-inhibiting S. epidermidis vaccine 
development. Pier and coworkers have significantly contributed to the evalua-
tion of PIA as vaccine target. Following the evidence, high-molecular-weight PIA 
could elicit an antibody response accompanied by opsonophagocytic killing of the 
PIA-dependent biofilm-forming S. epidermidis M187 and three S. aureus strains. The 
PIA-specific antibodies can prevent biofilm formation or retard already initiated 
biofilm development [35].
PIA biosynthesis depends on the expression of the icaADBC operon, which 
is controlled by a complex regulatory network. Gomes et al. studied the effect of 
rifampicin+gentamicin and rifampicin+clindamycin combinations on the expres-
sion of icaA and rsbU genes, responsible for poly-N-acetylglucosamine/polysaccha-
ride intercellular adhesin (PNAG/PIA) production. The results demonstrated that 
this combinatorial therapy can cause a lower genetic expression of the two specific 
genes tested and consequently can reduce biofilm formation recidivism [36, 37].
Nevertheless, S. epidermidis strains lacking icaADBC but still producing biofilm 
were isolated, indicating the existence of an ica-independent mechanism of cell 
accumulation. A proteinaceous intercellular adhesin involved in cell accumulation 
during biofilm formation was discovered. The accumulation-associated protein 
(Aap) can functionally substitute PIA as an intercellular adhesin, and there is good 
evidence that additional proteinaceous intercellular adhesins must exist. They 
showed that monoclonal antibodies against Aap can significantly reduce the accu-
mulation but not initiation phase of S. epidermidis biofilm formation in vitro [38].
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Biofilm formation is a result of bacterial interactions and group behavior. 
Quorum sensing (QS) is one of the regulatory mechanisms suggested to be involved 
in coordinating biofilm formation. The QS system is a cell-to-cell communication 
system used by many bacteria to assess the cell density. Quorum sensing inhibitors 
(QSI) could be a novel way to fight biofilm-associated infections. The study has 
identified furanones and thiophenones as inhibitors of quorum sensing and biofilm 
formation. In this study, the effect of both the furanone and the thiophenone could 
be abolished by the synthetic Autoinducer-2 (AI-2) molecule (S)-4,5-dihydroxy-
2,3-pentanedione (DPD), indicating that furanone and thiophenone affect biofilm 
formation through interference with bacterial communication [39].
4.3 Promotion of biofilm detachment
For the biofilm that has been formed on the surface of the host, if the biofilm 
can be separated by antibacterial oranti-biofilm substances, the bacteria in the 
biofilm can be released, and the planktonic bacteria are more easily to be killed if 
the biofilm is exposed to antibiotics. Biofilms are composed primarily of microbial 
cells and extracellular polymeric substance (EPS). EPS may account for 50–90% 
of the total organic carbon of biofilms and can be considered the primary matrix 
material of the biofilm. The components of EPS include polysaccharides, nucleic 
acids, lipids, and proteins [36].
We initially determined the dependent type of biofilm formation by S. epider-
midis ATCC 35984 and 5-121-2. The biofilm formation by S. epidermidis ATCC 
35984 mainly depends on EPS consisting of reducing polysaccharides in which 
dihydroxyl groups are unsubstituted. Thus, sodium-meta-periodate, which specifi-
cally destroys sugars containing unsubstituted dihydroxyl groups, significantly 
decreased biofilm formation in S. epidermidis ATCC 35984. However, not only EPS 
but also proteins, eDNA, are responsible for the biofilm formation of S. epider-
midis 5-121-2. Moreover, EPS in S. epidermidis 5-121-2, which mainly consists of 
nonreducing polysaccharides, is distinct with those in S. epidermidis ATCC 35984. 
Thus, three enzymes specific to nonreducing glycosides, amylase, β-glucanase, and 
β-glucosidase, worked effectively in the degradation of EPS, resulting in biofilm 
reduction in S. epidermidis 5-121-2 [19].
Since extracellular polysaccharides are the main compounds in biofilm matri-
ces, namely in S. epidermidis, antimicrobial substances able to disrupt or inhibit 
EPS are of major interest. N-acetylcysteine (NAC) is an amino acid with strong 
antioxidant, antimucolytic, and antibacterial properties. As observed by research-
ers, NAC decreased biofilm formation and reduced the formation of extracellular 
polysaccharide matrix while promoting the disruption of mature biofilm. NAC 
has demonstrated not only to reduce adhesion but also to detach bacterial cells 
adhered to surfaces and to inhibit bacterial growth in vitro. The possible action of 
NAC in the biofilm matrix can result in the release of cells either individually or in 
cell clusters, becoming the biofilm and loose cells more exposed and susceptible 
to the host immune system and to other antimicrobial agents [40]. Kaplan et al. 
found an enzyme called dispersin B, which can promote biofilm detachment 
from Actinobacillus actinomycetemconitans, which rapidly and effectively removes 
biofilms formed by S. epidermidis on the host surface. Dispersin B is a β-1,6-N-
Acetylglucosaminidase that causes S. epidermidis to detach from the biofilm matrix 
by degrading PIA [41].
Our results showed that EPS in S. epidermidis ATCC 35984 and 5-121-2 was 
degraded by crude proteins from three Actinomycete strains (TRM 41337, TRM 
46200, and TRM 46814) supernatants. Specifically, for the strain ATCC 35984 
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when treated with crude proteins from spent medium of the strain TRM 41337, 
arabinose (Ara) was absent in the monosaccharide composition compared with the 
control. Furthermore, the proportion of mannose (Man) was decreased, while the 
proportions of glucosamine (GluN), galactosamine (GalN), and galactose (Gal) 
were increased. When treated with crude proteins from spent medium of the strain 
TRM 46814, three new monosaccharides, rhamnose (Rha), glucuronic acid (GluA), 
and galacturonic acid (GalA), appeared. Additionally, the proportions of Man and 
glucose (Glu) decreased obviously. For the strain 5-121-2, when treated with crude 
proteins from spent media of TRM 41337 and TRM 46814, a new monosaccharide, 
Rha, was present [19].
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